May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Role of the Immune Modulator Programmed Cell Death-1 During Development and Apoptosis of Retinal Ganglion Cells
Author Affiliations & Notes
  • L. Chen
    Ophthalmology, Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California
    Molecular and Medical Pharmacology,
    University of California Los Angeles, Los Angeles, California
  • C. W. Sham
    Pathology and Laboratory Medicine,
    University of California Los Angeles, Los Angeles, California
  • X.-J. Yang
    Ophthalmology, Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California
  • A. H. Sharpe
    Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  • G. J. Freeman
    Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
    Medicine, Harvard Medical School, Boston, Massachusetts
  • J. Braun
    Pathology and Laboratory Medicine,
    University of California Los Angeles, Los Angeles, California
  • L. K. Gordon
    Ophthalmology, Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California
    Ophthalmology Section, Surgery and Perioperative Care, Greater Los Angeles VA Healthcare System, Los Angeles, California
  • Footnotes
    Commercial Relationships  L. Chen, None; C.W. Sham, None; X. Yang, None; A.H. Sharpe, None; G.J. Freeman, None; J. Braun, None; L.K. Gordon, None.
  • Footnotes
    Support  Research to Prevent Blindness James S. Adams Scholar (LKG)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3081. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Chen, C. W. Sham, X.-J. Yang, A. H. Sharpe, G. J. Freeman, J. Braun, L. K. Gordon; Role of the Immune Modulator Programmed Cell Death-1 During Development and Apoptosis of Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3081.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal ganglion cell (RGC) death is a critical step in the development of the mature retina and formation of effective neuronal networks. Novel neuronal expression of certain canonical molecules of the immune system is directly linked to neural functions. Programmed cell death-1 (PD-1) is an important receptor molecule regulating cell-cell signaling and clonal fate in the immune system. Our previous data showed constitutive expression of PD-1 in the retina and its dynamic regulation during retinal development. We hypothesize that active negative selection of neurons through PD-1 pathway may be required in RGC culling.

Methods: : Neonatal retinal explants were cultured in vitro for 24 hours in the presence of anti-PD-1 blocking monoclonal antibody or isotype matched control antibody. Apoptosis was evaluated by caspase-3 activation and decreased Brn3a expression. Neonatal and adult retinae from PD-1 deficient mouse were analyzed by quantification of RGC numbers.

Results: : Blockade of PD-1 signaling in vitro results in an increased and selective survival of RGCs, suggesting its significant function in RGC survival and programmed cell death. Dramatically increased Brn3a positive RGC number and RGC ratio were observed on PD-1 deficient mouse eye at postnatal day 2 and day 4, which is the peak of naturally occurring programmed cell death of RGCs in developing mouse retina, suggesting the role of PD-1 in the survival of RGCs during the postnatal critical period.

Conclusions: : These findings suggest that the PD-1 mediated signaling pathway plays a novel role in the developmental programmed cell death during postnatal RGC maturation. These observations support the concept of negative selection, similar to the active process of lymphocyte maturation, in neuronal development. Our results could lead to enhanced understanding of the complex mechanisms contributing to neuronal cell death and survival in disease conditions, since the molecular pathogenesis of neurodegenerative disorders in RGCs might be similar to the mechanisms of developmental apoptosis.

Keywords: retinal development • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×